Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients

To identify better regimens in currently available chemotherapy would be beneficial to KRAS mutant metastatic colorectal cancer (mCRC) patients because they have fewer treatment options than KRAS wild-type mCRC patients. Clinicopathologic features and overall survival (OS) of KRAS mutant and wild-ty...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lin, Yu-Lin, Liang, Yi-Hsin, Tsai, Jia-Huei, Liau, Jau-Yu, Liang, Jin-Tung, Lin, Been-Ren, Hung, Ji-Shiang, Lin, Liang-In, Tseng, Li-Hui, Chang, Yih-Leong, Yeh, Kun-Huei, Cheng, Ann-Lii
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913571/
https://ncbi.nlm.nih.gov/pubmed/24505265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0086789
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados